Sir John Vane, Director, Research & Development
- Part of
- Wellcome Foundation Ltd
- Archives and manuscripts
About this work
During Vane's period as Director, Wellcome discovered prostacyclin (a short-lived hormone that dilates blood vessels and prevents platelet aggregation), and produced a number of important drugs including anti-viral agents and muscle relaxants. Material on vaccines for whooping cough and rubella is also present. The files record, from a company executive perspective, the search for new compounds in a competitive commercial context. Considerable executive energy in this period was also given to organizational restructuring, which is recorded in some detail.